Insight Molecular Diagnostics Inc. (IMDX) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $1.75M | +66.2% |
| 2024 | $1.05M | +5.1% |
| 2023 | $1.00M | +13.9% |
| 2022 | $880.0K | +26.3% |
| 2021 | $697.0K | -62.4% |
| 2020 | $1.85M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $1.75M | +66.2% |
| 2024 | $1.05M | +5.1% |
| 2023 | $1.00M | +13.9% |
| 2022 | $880.0K | +26.3% |
| 2021 | $697.0K | -62.4% |
| 2020 | $1.85M | — |